In Silico Study of Black Garlic (Allium sativum) Against COX-2 in Anti-Inflammatory Therapy

Authors

  • Riki Agustin Maulana Department of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran
  • Alya Azzahra Ramadhani Department of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran
  • Nafisa Shoya Ifara Department of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran
  • Dzava Prawinsyah Fairus Ismail Department of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran
  • Febby Pratama Department of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran
  • Sabiq Salmandhiya Harits Department of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran
  • Rina Fajri Nuwarda Department of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran

DOI:

https://doi.org/10.24002/biota.v11i2.14292

Keywords:

Anti-inflammatory, Inflammation, Black garlic, COX-2, Molecular docking

Abstract

Cyclooxygenase-2 (COX-2) is an inducible enzyme involved in prostaglandin biosynthesis during inflammatory processes and represents an important therapeutic target for anti-inflammatory drug development. Black garlic (Allium sativum) contains bioactive compounds such as S-allyl cysteine (SAC), 5-hydroxymethylfurfural, and flavonols with reported anti-inflammatory potential. This study aimed to investigate the potential of black garlic-derived compounds as COX-2 inhibitors using an in silico approach. Twenty-four compounds were evaluated through Lipinski’s Rule of Five, ADMET prediction, ligand-based pharmacophore screening, and molecular docking using the COX-2 crystal structure (PDB ID: 3LN1), with celecoxib as the reference inhibitor. In contrast, 5-hydroxymethylfurfural demonstrated high intestinal absorption and strong pharmacophore similarity to celecoxib, although its binding affinity was comparatively low. Flavonols showed the best docking performance, characterized by binding energy of −8.18 kcal/mol, high pharmacophore fit scores, and acceptable pharmacokinetic profiles. However, toxicity prediction suggested that both 5-hydroxymethylfurfural and flavonols may possess mutagenic and carcinogenic potential. Overall, flavonols and 5-hydroxymethylfurfural may warrant further investigation as potential COX-2-targeting compounds, although molecular dynamics, in vitro, and in vivo studies are needed to validate their activity and safety.

References

Abdulkhaleq, L. A., Assi, M. A., Abdullah, R., Zamri-Saad, M., Taufiq-Yap, Y. H., & Hezmee, M. N. M. (2018). The crucial roles of inflammatory mediators in inflammation: A review. Veterinary World, 11(5), 627–635. https://doi.org/10.14202/vetworld.2018.627-635

Ahmadi, M., Bekeschus, S., Weltmann, K.-D., von Woedtke, T., & Wende, K. (2022). Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors. RSC Medicinal Chemistry, 13(5), 471–496. https://doi.org/10.1039/D1MD00280E

Ahmed, T., & Wang, C. K. (2021). Black garlic and its bioactive compounds on human health diseases: A review. In Molecules (Vol. 26, Number 16). MDPI AG. https://doi.org/10.3390/molecules26165028

Alexanian, A., & Sorokin, A. (2017). Cyclooxygenase 2: protein-protein interactions and posttranslational modifications Alexanian A, Sorokin A. Cyclooxygenase 2: protein-protein interactions and posttranslational modifications. Physiol Genomics, 49, 667–681. https://doi.org/10.1152/physiolgenomics.00086.2017.-Numer

Allo, V. L., Rahmah, S., & Gunawan, R. (2023). Studi Molecular Docking Senyawa Turunan Auron Sebagai Inhibitor Glikoprotein Spike SARS-COV-2. Akta Kimia Indonesia, 8(2), 126. https://doi.org/10.12962/j25493736.v8i2.16827

Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the Rule of 5 and drugability. In Advanced Drug Delivery Reviews, 101, 89–98. https://doi.org/10.1016/j.addr.2016.05.007

Celestin, M. N., & Musteata, F. M. (2021). Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States. In Journal of Pharmaceutical Sciences. 110 (10), 3331–3344. https://doi.org/10.1016/j.xphs.2021.05.018

Czub, N., Szlęk, J., Pacławski, A., Klimończyk, K., Puccetti, M., & Mendyk, A. (2023). Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity. Molecular Pharmaceutics, 20(5), 2545–2555. https://doi.org/10.1021/acs.molpharmaceut.2c01117

Gilman, K. E., & Limesand, K. H. (2021). The complex role of prostaglandin E2-EP receptor signaling in wound healing. In American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 320(3), R287–R296. https://doi.org/10.1152/AJPREGU.00185.2020

Guo, Q., Xu, J., Shi, Q., & Wu, S. (2020). PDLIM2 protects articular chondrocytes from lipopolysaccharide-induced apoptosis, degeneration and inflammatory injury through down-regulation of nuclear factor (NF)-κB signaling. International Immunopharmacology, 88, 106883. https://doi.org/10.1016/j.intimp.2020.106883

Harutyunyan, K., Nersesova, L., Ayvazyan, V., Avagyan, E., Melkumyan, M., Sargsyan, M., Tatikyan, S., Karalyan, Z., Avagyan, H., Harutyunyan, A., Tsakanova, G., & Babayan, N. (2025). In silico and in vitro evaluation of drug-like properties and anticancer potential of novel 5-fluorouracil derivatives. Scientific Reports, 15(1), 39689. https://doi.org/10.1038/s41598-025-23237-y

Hasan, R., & Herowati, R. (2024). Molecular Docking and Pharmacokinetic Studies of Moringa oleifera As Angiotensin-Converting Enzyme Inhibitors. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 11(1), 80–88. https://doi.org/10.20473/jfiki.v11i12024.80-88

Karaküçük, A., Taşhan, E., Öztürk, N., & Çelebi, N. (2021). In vitro caco-2 cell permeability studies of ziprasidone hydrochloride monohydrate nanocrystals. Turkish Journal of Pharmaceutical Sciences, 18(2), 223–227. https://doi.org/10.4274/tjps.galenos.2020.67366

Kong, F., Lee, B. H., & Wei, K. (2019). 5-Hydroxymethylfurfural Mitigates Lipopolysaccharide-Stimulated Inflammation via Suppression of MAPK, NF-κB and mTOR Activation in RAW 264.7 Cells. Molecules, 24(2), 275. https://doi.org/10.3390/molecules24020275

Kumaeum, W., & Jaiyong, P. (2025). Design and Computational Study of Sulfonamide-Modified Cannabinoids as Selective COX-2 Inhibitors Using Semiempirical Quantum Mechanical Methods: Drug-like Properties and Binding Affinity Insights. ACS Omega, 10(13), 13605–13620. https://doi.org/10.1021/acsomega.5c00562

Latief, M., Fisesa, A.T., Sari, P. M., & Tarigan, I.L. (2021). Aktivitas Antiinflamasi Ekstrak Etanol Daun Sungkai (Peronema Canescens Jack) Pada Mencit Terinduksi Karagenan. Jurnal Farmasi Sains dan Praktis. 7(2), 144-153.

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/10.1016/j.addr.2012.09.019

Liu, J., Grohganz, H., & Rades, T. (2020). Influence of polymer addition on the amorphization, dissolution and physical stability of co-amorphous systems. International Journal of Pharmaceutics, 588, 119768. https://doi.org/https://doi.org/10.1016/j.ijpharm.2020.119768

Manoonphol, K., Suttisansanee, U., Promkum, C., & Butryee, C. (2023). Effect of Thermal Processes on S-Allyl Cysteine Content in Black Garlic. Foods, 12(6). https://doi.org/10.3390/foods12061227

Medzhitov, R. (2021). The spectrum of inflammatory responses. Science, 374(6571), 1070–1075. https://doi.org/10.1126/science.abi5200

Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Molecular Docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602

Mong, M., & Yin, M. (2012). Nuclear Factor κB-Dependent Anti-inflammatory Effects of s -Allyl Cysteine and s -Propyl Cysteine in Kidney of Diabetic Mice. Journal of Agricultural and Food Chemistry, 60(12), 3158–3165. https://doi.org/10.1021/jf3002685

Moussa, N., Hassan, A., & Gharaghani, S. (2021). Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors. Heliyon, 7(4). https://doi.org/10.1016/j.heliyon.2021.e06605

Muchtaridi, M., Syahidah, H. N., Subarnas, A., Yusuf, M., Bryant, S. D., & Langer, T. (2017). Molecular docking and 3D-pharmacophore modeling to study the interactions of chalcone derivatives with estrogen receptor alpha. Pharmaceuticals, 10(4). https://doi.org/10.3390/ph10040081

Najman, K., Sadowska, A., & Hallmann, E. (2021). Evaluation of bioactive and physicochemical properties of white and black garlic (Allium sativum l.) from conventional and organic cultivation. Applied Sciences (Switzerland), 11(2), 1–23. https://doi.org/10.3390/app11020874

Opo, F. A. D. M., Moulay, M., Zari, A., Alqaderi, A., Alkarim, S., Zari, T., Bhuiyan, M. A., Mahmoud, M. M., Aljoud, F., Suhail, M., Edris, S., Ramadan, W. S., Kamal, M. A., Nemmiche, S., & Ahammad, F. (2022). Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.1027890

Pahwa, R., Goyal, A., & Jialal, I. (2023). Chronic inflammation. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from https://www.ncbi.nlm.nih.gov/books/NBK493173

Pantaleão, S. Q., Fernandes, P. O., Gonçalves, J. E., Maltarollo, V. G., & Honorio, K. M. (2022). Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review. ChemMedChem, 17(1). https://doi.org/10.1002/cmdc.202100542

Rayar, A.-M., Lagarde, N., Ferroud, C., Zagury, J.-F., Montes, M., & Sylla-Iyarreta Veitia, M. (2017). Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases. Current Topics in Medicinal Chemistry, 17(26). https://doi.org/10.2174/1568026617666170821124947

Shultz, M. D. (2019). Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. Journal of Medicinal Chemistry, 62(4), 1701–1714. https://doi.org/10.1021/acs.jmedchem.8b00686

Stępień, A. E., Trojniak, J., & Tabarkiewicz, J. (2024). Anti-Cancer and Anti-Inflammatory Properties of Black Garlic. In International Journal of Molecular Sciences. 25(3). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/ijms25031801

Tech, M. E., Magalhães, C. G., & Vieira Filho, S. A. (2022). Secondary metabolites and pharmacological potential of Thuja orientalis and T. occidentalis: A short review. Ecletica Quimica Journal, 47(4), 17–26. https://doi.org/10.26850/1678-4618eqj.v47.4.2022.p17-26

U.S. Food and Drug Administration. (2021). M9 Biopharmaceutics Classification System-Based Biowaivers Guidance for Industry. https://www.fda.gov/vaccines-blood-biologics/guidance-compliance-regulatory-information-biologics/biologics-guidances

Vecchi, V., Sabbioni, G., Altieri, M. T., Breveglieri, G., Costa, S., Marchetti, F., Gugel, I., Vertuani, S., & Borgatti, M. (2025). Black Garlic: Evolution of the Chemical Composition and Broad Biological Activities. Journal of Agricultural and Food Chemistry. 73(44), 27933–27949. https://doi.org/10.1021/acs.jafc.5c09705

Vitale, E., Rizzo, A., Santa, K., & Jirillo, E. (2024). Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping Review. Biology, 13(5), 352. https://doi.org/10.3390/biology13050352

Wautier, J. L., & Wautier, M. P. (2023). Pro- and Anti-Inflammatory Prostaglandins and Cytokines in Humans: A Mini Review. In International Journal of Molecular Sciences. 24(11), 9647. https://doi.org/10.3390/ijms24119647

Downloads

Published

27-06-2026

How to Cite

Maulana, R. A., Ramadhani , A. A., Ifara, N. S., Ismail, D. P. F., Pratama, F., Harits, S. S., & Nuwarda, R. F. (2026). In Silico Study of Black Garlic (Allium sativum) Against COX-2 in Anti-Inflammatory Therapy. Biota : Jurnal Ilmiah Ilmu-Ilmu Hayati, 11(2), 249–264. https://doi.org/10.24002/biota.v11i2.14292

Issue

Section

Articles